Abstract
Bullous pemphigoid is the most common autoimmune bullous disease. It usually appears as a very itchy rash of urticarial or eczematous appearance, with subsequent appearance of vesicles and tense blisters on previously inflamed skin. The basis of its pathogenesis consists of the production of autoantibodies that attacks several components of the hemidesmosomes which are located in the basal membrane of the dermoepidermal junction. Localized bullous pemphigoid is a rare clinical variant of bullous pemphigoid. It normally appears in the lower extremities and it’s rarer on palms or on the breast. Several causes have been described, such as physical trauma, ultraviolet radiation, and, in the case of localized bullous pemphigoid on the breast, radiotherapy or ductal carcinoma, although it is not always possible to find an underlying cause.
This is a preview of subscription content, log in via an institution.
References
Mutasim DF. Autoimmune bullous dermatoses in the elderly: an update on pathophysiology, diagnosis and management. Drugs Aging. 2010;1:1–19.
Isohashi F, Konishi K, Umegaki N, Tanei T, Koizumi M, Yoshioka Y. A case of bullous pemphigoid exacerbated by irradiation after breast conservative radiotherapy. Jpn J Clin Oncol. 2011;41(6):811–3.
Mul VE, van Geest AJ, Pijls-Johannesma MC, Theys J, Verschueren TA, Jager JJ, et al. Radiation-induced bullous pemphigoid: a systematic review of an unusual radiation side effect. Radiother Oncol. 2007;82:5–9.
Mul VE, Verschueren TA, van Geest AJ, Baumert BG. Bullous Pemphigoid (BP) induced by radiotherapy. Radiother Oncol. 2007;82:105.
Anzai S, Ueo D, Fujiwara S. A case of bullous pemphigoid exacerbated by radiotherapy. Vis Dermatol. 2009;8:32–3.
Weiss G, Shemer A, Trau H. The Koebner phenomenon: review of the literature. J Eur Acad Dermatol Venereol. 2002;16:241–8.
Luliano L, Micheletta F, Natoli S. Bullous pemphigoid: an unusual and insidious presentation of breast cancer. Clin Oncol. 2003;15(8):505.
Vaughan Jones SA, Salas J, McGrath JA, Palmer I, Bhogal GS, Black MM. A retrospective analysis of tissue-fixed immunoreactants from skin biopsies maintained in Michel’s medium. Dermatology. 1994;189(Suppl 1):131–2.
Yancey KB, Egan CA. Pemphigoid: clinical, histologic, immunopathologic, and therapeutic considerations. JAMA. 2000;284:350–6.
Iwata Y, Komura K, Kodera M, Usuda T, Yokoyama Y, Hara T, Muroi E, Ogawa F, Takenaka M, Sato S. Correlation of IgE autoantibody to BP180 with a severe form of bullous pemphigoid. Arch Dermatol. 2008;144:41–8.
Westerhof W. Treatment of bullous pemphigoid with topical clobetasol propionate. J Am Acad Dermatol. 1989;20:458–61.
Ingen-Housz-Oro S, Valeyrie-Allanore L, Ortonne N, Roujeau JC, Wolkenstein P, Chosidow O. Management of bullous pemphigoid with topical steroids in the clinical practice of a single center: outcome at 6 and 12 months. Dermatology. 2011;222:176–9.
Morel P, Guillaume JC. Treatment of bullous pemphigoid with prednisolone only: 0.75 mg/kg/day versus 1.25 mg/kg/day. A multicenter randomized study. Ann Dermatol Venereol. 1984;111:925–8.
Venning VA, Millard PR, Wojnarowska F. Dapsone as first line therapy for bullous pemphigoid. Br J Dermatol. 1989;120:83–92.
Fivenson D, Breneman D, Rosen G, Hersh CS, Cardone S, Mutasim D. Nicotinamide and tetracycline therapy of bullous pemphigoid. Arch Dermatol. 1994;130:753–8.
Kirtschig G, Khumalo NP. Management of bullous pemphigoid: recommendations for immunomodulatory treatments. Am J Clin Dermatol. 2004;5:319–26.
Heilborn JD, Ståhle-Bäckdahl M, Albertioni F, Vassilaki I, Peterson C, Stephansson E. Low-dose oral pulse methotrexate as monotherapy in elderly patients with bullous pemphigoid. J Am Acad Dermatol. 1999;40:741–9.
Burton JL, Harman RR, Peachey RD, Warin RP. Azathioprine plus prednisone in treatment of pemphigoid. Br Med J. 1978;28:1190–1.
Grundmann-Kollmann M, Korting HC, Behrens S, Kaskel P, Leiter U, Krähn G, Kerscher M, Peter RU. Mycophenolate mofetil: a new therapeutic option in the treatment of blistering autoimmune diseases. J Am Acad Dermatol. 1999;40(6 Pt 1):957–60.
Lourari S, Herve C, Doffoel-Hantz V, Meyer N, Bulai-Livideanu C, Viraben R, Maza A, Adoue D, Bedane C, Paul C. Bullous and mucous membrane pemphigoid show a mixed response to rituximab: experience in seven patients. J Eur Acad Dermatol Venereol. 2011;25:1238–40.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG
About this chapter
Cite this chapter
Nevado, Á.V., Ceballos, E.H. (2018). Bullous Pemphigoid on the Areola of Breast. In: Shiffman, M. (eds) Nipple-Areolar Complex Reconstruction. Springer, Cham. https://doi.org/10.1007/978-3-319-60925-6_19
Download citation
DOI: https://doi.org/10.1007/978-3-319-60925-6_19
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-60924-9
Online ISBN: 978-3-319-60925-6
eBook Packages: MedicineMedicine (R0)